Balchem Co. (NASDAQ:BCPC)’s share price reached a new 52-week high on Tuesday . The stock traded as high as $107.18 and last traded at $107.16, with a volume of 4373 shares. The stock had previously closed at $106.41.
Several research analysts have recently weighed in on BCPC shares. ValuEngine lowered shares of Balchem from a “hold” rating to a “sell” rating in a research note on Saturday, January 4th. HC Wainwright restated a “positive” rating and set a $110.00 price objective (up from $95.00) on shares of Balchem in a research note on Wednesday, November 6th. BidaskClub lowered shares of Balchem from a “hold” rating to a “sell” rating in a research note on Thursday, November 21st. Finally, Zacks Investment Research lowered shares of Balchem from a “hold” rating to a “sell” rating in a research note on Friday, January 3rd. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $107.67.
The company has a market capitalization of $3.36 billion, a price-to-earnings ratio of 35.80 and a beta of 1.18. The firm’s 50 day moving average price is $101.94 and its two-hundred day moving average price is $98.38. The company has a current ratio of 3.33, a quick ratio of 2.31 and a debt-to-equity ratio of 0.32.
The firm also recently announced an annual dividend, which will be paid on Friday, January 17th. Shareholders of record on Monday, December 30th will be given a dividend of $0.52 per share. This represents a dividend yield of 0.51%. The ex-dividend date is Friday, December 27th. This is a positive change from Balchem’s previous annual dividend of $0.47. Balchem’s dividend payout ratio is presently 17.28%.
A number of large investors have recently modified their holdings of BCPC. Tower Research Capital LLC TRC bought a new position in Balchem in the 2nd quarter valued at approximately $65,000. First Mercantile Trust Co. bought a new position in shares of Balchem during the third quarter valued at $72,000. HM Payson & Co. bought a new position in shares of Balchem during the second quarter valued at $147,000. Balyasny Asset Management LLC bought a new position in shares of Balchem during the second quarter valued at $206,000. Finally, MML Investors Services LLC bought a new position in shares of Balchem during the second quarter valued at $213,000. 87.88% of the stock is owned by institutional investors and hedge funds.
Balchem Company Profile (NASDAQ:BCPC)
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Further Reading: What is a stock portfolio tracker?
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.